Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Survival among women with triple receptor-negative breast cancer and brain metastasesS Dawood, K Broglio, F J Esteva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2008
Defining prognosis for women with breast cancer and CNS metastases by HER2 statusS Dawood, K Broglio, F J Esteva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancerE Rivera, V Valero, L Syrewicz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2007
Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancerF Andre, R Nahta, R Conforti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 2008
Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumabF Peintinger, A U Buzdar, H M Kuerer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapyT A Buchholz, S L Tucker, J Erwin, et al.
Cancer Chemotherapy and Pharmacology|August 21, 2019
Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trialF J Esteva, Y V Baranau, V Baryash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplificationA D Seidman, M N Fornier, F J Esteva, et al.
Pageof 3